Eisai Limited
Wholesale of pharmaceutical goods · Hatfield
ActiveUnited KingdomIncorporated 1988Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
02242511- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1988-04-11
- Jurisdiction
- —
- Registered office
- 1EUROPEAN KNOWLEDGE CENTRE, MOSQUITO WAY, HATFIELD, HERTS, AL10 9SN
Classification
2 SIC codes4646072190
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
12 matched grantsMICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActiveMRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants£13,635,487whole project
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActive
MRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants
£13,635,487
whole project
University Of OxfordleadAlectorAlzheimer'S Research UKAlzheimers SocietyApellis PharmaceuticalAstraZenecaAutifony Therapeutics LimitedBoostecBrainDTech SpACambridge Cognition LtdCardiff UniversityCatalan Health Institute (ICS)Cognetivity LtdCytOx LimitedDanish Research Centre for Magnetic Resonance (DRCMR)Eisai LtdEli Lilly & Company LtdEli Lilly (United Kingdom)EMBL European Bioinformatics Institute (EMBL - EBI)European Bank for induced pluripotent Stem CellsFerrer InternacionalF. Hoffmann-La Roche AGFlame UniversityGates Ventures, LLC.German Centre for Neurodegenerative DiseasesGlobal Alzheimer's Platform FoundationGskHarvard UniversityIMI Europe LimitedIrish Critical Care Clinical Trials NetworkIXICO Technologies LtdJanssen Research & Development LLCKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo ClinicMcGill UniversityMedical Research Council (MRC)National Institute for Health and Care ResearchNational Institutes of Health (NIH)Roche PharmaceuticalsRodin Therapeutics, Inc.Rush University Medical CenterSouth Kazakhstan Medical AcademyStanford UniversityThe Hong Kong University of Science and TechnologyUCB PharmaUniversity College CopenhagenUniversity College LondonUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity Of EdinburghUniversity of GlasgowUniversity of GothenburgUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity Of ManchesterUniversity Of NottinghamUniversity of San FranciscoUniversity of TorontoVU University Medical Center
Dissecting molecular mechanisms of Parkinson's diseaseMRC · Fellowship · 2020-03-31 – 2025-11-30 · with 6 other participants£1,902,259whole project
Dissecting molecular mechanisms of Parkinson's disease
MRC · Fellowship · 2020-03-31 – 2025-11-30 · with 6 other participants
£1,902,259
whole project
University College LondonleadEisai LtdFrancis Crick InstituteMerckUniversity College LondonUniversity of CambridgeUniversity of Dundee
Brain Iron Toxicity and Neurodegeneration - MRI study at 7TMRC · Research Grant · 2019-09-01 – 2024-03-01 · with 3 other participants£194,530whole project
Brain Iron Toxicity and Neurodegeneration - MRI study at 7T
MRC · Research Grant · 2019-09-01 – 2024-03-01 · with 3 other participants
£194,530
whole project
Trials Methodology Research PartnershipMRC · Research Grant · 2019-05-31 – 2023-01-31 · with 53 other participants£395,205whole project
Trials Methodology Research Partnership
MRC · Research Grant · 2019-05-31 – 2023-01-31 · with 53 other participants
£395,205
whole project
University of LiverpoolleadAmgen IncAstrazenecaBangor UniversityBayerCardiff UniversityCardiff UniversityEisai LtdGlaxoSmithKline (GSK)Health Data Research UKInstitute of Cancer ResearchInstitute of Cancer Research UKJohnson & JohnsonKenyan Institute for Medical Research (KEMRI)King Edward Memorial Hospital Research CentreKing'S College LondonLancaster UniversityLancaster UniversityLiverpool School of Tropical MedicineLiverpool School Of Tropical MedicineMakerere University College of Health SciencesMedical Research Council (MRC)Medical Research Council of South Africa (MRC)Muhimbili University of Health and Allied SciencesNewcastle UniversityNewcastle UniversityQueen Mary University Of Londonroche pharmaceuticalsSoroti UniversityThe Global Health NetworkTrials Methodology Research NetworkUKCRC Registered trials CTU networkUK Trial Managers NetworkUniversity College LondonUniversity College LondonUniversity of AberdeenUniversity Of AberdeenUniversity Of BirminghamUniversity of BristolUniversity of CambridgeUniversity Of CambridgeUniversity of Cape TownUniversity Of East AngliaUniversity Of EdinburghUniversity Of ExeterUniversity of GalwayUniversity of LeedsUniversity Of ManchesterUniversity Of NottinghamUniversity Of OxfordUniversity Of PlymouthUniversity of SheffieldUniversity of WarwickUniversity Of York
MICA: Development of new agents for the treatment of cryptosporidiosisMRC · Research Grant · 2019-04-30 – 2023-01-31 · with 3 other participants£2,165,959whole project
MICA: Development of new agents for the treatment of cryptosporidiosis
MRC · Research Grant · 2019-04-30 – 2023-01-31 · with 3 other participants
£2,165,959
whole project
University Of DundeeleadEisai Inc.Eisai LtdUniversity of Vermont
Molecular Genetic Studies of SchizophreniaMRC · Research Grant · 2016-12-01 – 2022-11-30 · with 25 other participants£2,407,099whole project
Molecular Genetic Studies of Schizophrenia
MRC · Research Grant · 2016-12-01 – 2022-11-30 · with 25 other participants
£2,407,099
whole project
Cardiff UniversityleadCardiff UniversityCatalan Health Institute (ICS)Eisai LtdEMBL European Bioinformatics Institute (EMBL - EBI)German Centre for Neurodegenerative DiseasesHarvard UniversityImperial College LondonIndian Institute of Science BangaloreMedical Research Council (MRC)National Institutes of Health (NIH)Psychiatric Genomics Consortium (PGC)South Kazakhstan Medical AcademyStanford UniversityTakeda Pharmaceutical CompanyUniversidade de São PauloUniversity College LondonUniversity of BristolUniversity of California, IrvineUniversity of CambridgeUniversity Of EdinburghUniversity of GlasgowUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity Of Oxford
IMPC: Characterisation a novel Alzheimer's disease susceptibility locusMRC · Research Grant · 2016-12-01 – 2018-11-30 · with 2 other participants£24,316whole project
IMPC: Characterisation a novel Alzheimer's disease susceptibility locus
MRC · Research Grant · 2016-12-01 – 2018-11-30 · with 2 other participants
£24,316
whole project
UK Dementias PlatformMRC · Research Grant · 2015-08-31 – 2023-07-30 · with 84 other participants£15,256,623whole project
UK Dementias Platform
MRC · Research Grant · 2015-08-31 – 2023-07-30 · with 84 other participants
£15,256,623
whole project
University Of OxfordleadAlan Turing InstituteAlectorAlzheimer's Disease Neuroimaging InitiativeAlzheimer's Research UKAmyloid Imaging to Prevent Alzheimer's DiseaseApellis PharmaceuticalAraclon BiotechAstrazenecaBarcelona Beta Brain Research CenterBoostecBristol-Myers SquibbCardiff UniversityCatalan Health Institute (ICS)Danish Research Centre for Magnetic Resonance (DRCMR)Eisai LtdEli Lilly & Company LtdEMBL European Bioinformatics Institute (EMBL - EBI)ETH ZurichEU Joint Programme - Neurodegenerative Disease Research (JPND)European Medical Information Framework (EMIF)Ferrer InternacionalFlame UniversityGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Government of WalesHarvard UniversityImperial College LondonIRCCS Policlinico San DonatoIrish Critical Care Clinical Trials NetworkIxicoJanssen Biotech, Inc.Janssen Research & DevelopmentJohnson & JohnsonKing'S College LondonLife Molecular ImagingLudwig Maximilian University of Munich (LMU Munich)McGill UniversityMedical Research Council (MRC)MRC Dementias Platform UKNational Institute on AgingNational Institutes of Health (NIH)Newcastle UniversityObservational Health Data Sciences and InformaticsOxford University Hospitals NHS Foundation TrustPolytechnic University of MilanProgressive Supranuclear Palsy Association (PSPA)Rush University Medical CenterSomaLogicStanford UniversitySwansea UniversityThe Hong Kong University of Science and TechnologyThe International Parkinson Disease Genomics ConsortiumUK Dementia Research InstituteUniversity College CopenhagenUniversity College LondonUniversity of BarcelonaUniversity of BolognaUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity Of East AngliaUniversity Of EdinburghUniversity of ExeterUniversity of GlasgowUniversity of GothenburgUniversity of GöttingenUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity of LiverpoolUniversity of LuxembourgUniversity Of ManchesterUniversity of MilanUniversity Of NottinghamUniversity of OsloUniversity of San FranciscoUniversity of Southern CaliforniaUniversity of Southern DenmarkUniversity of TorontoVU University Medical CenterWashington University in St LouisWAVE Life SciencesWellcome Trust
UKDP: Integrated DEmentiA research environment (IDEA)MRC · Research Grant · 2015-06-30 – 2016-06-29 · with 18 other participants£1,899,000whole project
UKDP: Integrated DEmentiA research environment (IDEA)
MRC · Research Grant · 2015-06-30 – 2016-06-29 · with 18 other participants
£1,899,000
whole project
University College LondonleadAligning Sciences Across Parkinson'sAlzheimer's Research UKAstrazenecaCardiff UniversityCerevance LtdDementia Discovery FundEisai LtdFrancis Crick InstituteJohnson & JohnsonNational Institute of Allergy and Infectious Diseases (NIAID)Perkin ElmerStanford UniversityUniversity College LondonUniversity of AntwerpUniversity of CambridgeUniversity Of EdinburghUniversity Of ManchesterUniversity Of Oxford
MRC Centre for Neuropsychiatric Genetics and GenomicsMRC · Research Grant · 2014-11-25 – 2019-11-24 · with 101 other participants£1,866,704whole project
MRC Centre for Neuropsychiatric Genetics and Genomics
MRC · Research Grant · 2014-11-25 – 2019-11-24 · with 101 other participants
£1,866,704
whole project
Cardiff UniversityleadAlbert Ludwig University of FreiburgAsterandAstrazenecaAutonomous University of MadridBangor UniversityBlissBoston UniversityBrigham Young UniversityBroad InstituteCardiff Metropolitan UniversityCardiff UniversityCatalan Health Institute (ICS)Central Institute for Mental HealthCHDI FoundationEisai LtdEMBL European Bioinformatics Institute (EMBL - EBI)Eu-T0FACE Recording & Measurement Systems LtdFondazione Santa LuciaFoundation for Prader-Willi Research (FPWR)Free University of BerlinFriedrich-Alexander University Erlangen-NurembergGenetic and Environmental Risk in Alzheimer's Disease (GERAD)Genetic Architecture of Rate of Alzheimer’s Decline (GENAROAD) ConsortiumGenomics EnglandGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Goethe University FrankfurtGW PharmaceuticalsHarvard UniversityHealth and Care Research WalesHelmholtz Association of German Research CentresHospital de Sant PauImperial College LondonIndian Institute of Science BangaloreInternational Multicentre persistent ADHD CollaboraTion (IMpACT)Italian Institute of Technology (Istituto Italiano di Tecnologia IIT)JPND ResearchKarolinska InstituteKing'S College LondonLancaster UniversityLudwig Maximilian University of Munich (LMU Munich)Massachusetts General HospitalMayo Foundation for Medical Education and Research (MFMER)Medical Research Council (MRC)Medical University of SofiaMount Sinai Hospital (USA)MRC HarwellNational Center for Biotechnology Information (NCBI)National Institute for Health and Care ResearchNational Institute of Health and Medical Research (INSERM)National Institutes of Health (NIH)Neuroscience; IOPOxford University Hospitals NHS Foundation TrustPsychiatric Genomics Consortium (PGC)Psychiatric GWAS Consortium (PGC)Queen's University BelfastRenishaw PlcSaarland UniversitySapienza University of RomeSocial Research Unit at DartingtonSouth Kazakhstan Medical AcademyStanford UniversitySwansea UniversityTakeda Pharmaceutical CompanyThe Jackson LaboratoryTrinity College DublinUniversidade de São PauloUniversity College LondonUniversity Duisburg-EssenUniversity of BathUniversity of BonnUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity of CantabriaUniversity of DublinUniversity Of EdinburghUniversity of ExeterUniversity of GlasgowUniversity of HamburgUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity of LiverpoolUniversity Of ManchesterUniversity of NavarraUniversity Of NottinghamUniversity of OregonUniversity of OviedoUniversity Of OxfordUniversity of PennsylvaniaUniversity of SouthamptonUniversity Of SussexUniversity of WashingtonUniversity of WurzburgUniversity of ZurichWashington University in St LouisWellcome Sanger InstituteWellcome Trust
PERADES: Defining Genetic, Polygenic and Environmental Risk for Alzheimer's Disease using multiple powerful cohorts, focussed Epigenetics and StemMRC · Research Grant · 2014-04-30 – 2017-12-31 · with 44 other participants£994,347whole project
PERADES: Defining Genetic, Polygenic and Environmental Risk for Alzheimer's Disease using multiple powerful cohorts, focussed Epigenetics and Stem
MRC · Research Grant · 2014-04-30 – 2017-12-31 · with 44 other participants
£994,347
whole project
Cardiff UniversityleadAlbert Ludwig University of FreiburgBangor UniversityBrigham Young UniversityCentral Institute for Mental HealthEisai LtdErasmus MCFree University of BerlinFriedrich-Alexander University Erlangen-NurembergGenetic Architecture of Rate of Alzheimer’s Decline (GENAROAD) ConsortiumGenomics EnglandGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Goethe University FrankfurtHelmholtz Association of German Research CentresHospital de Sant PauImperial College LondonKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo Foundation for Medical Education and Research (MFMER)Medical Research Council (MRC)National Center for Biotechnology Information (NCBI)National Institute of Health and Medical Research (INSERM)National Institutes of Health (NIH)Oxford University Hospitals NHS Foundation TrustPasteur Institute, LilleQueen's University BelfastSwansea UniversityThe Jackson LaboratoryTrinity College DublinUniversity College LondonUniversity Duisburg-EssenUniversity of BonnUniversity of BristolUniversity of CambridgeUniversity of ExeterUniversity of HamburgUniversity Of ManchesterUniversity Of NottinghamUniversity of PennsylvaniaUniversity of SouthamptonUniversity of ZurichVU University Medical CenterWashington University in St LouisWellcome Sanger Institute
Further defining the genetic architecture of Alzheimer's diseaseMRC · Research Grant · 2013-08-28 – 2019-01-31 · with 66 other participants£2,739,222whole project
Further defining the genetic architecture of Alzheimer's disease
MRC · Research Grant · 2013-08-28 – 2019-01-31 · with 66 other participants
£2,739,222
whole project
Cardiff UniversityleadAlbert Ludwig University of FreiburgArizona Association for Play TherapyAutonomous University of MadridBangor UniversityBoston UniversityBrigham Young UniversityCardiff UniversityCentral Institute for Mental HealthDepartment of Health Social Services and Public Safety (DHSSPS)Eisai LtdEli Lilly & Company LtdErasmus MCFondazione Santa LuciaFree University of BerlinFriedrich-Alexander University Erlangen-NurembergGenetic and Environmental Risk in Alzheimer's Disease (GERAD)Genetic Architecture of Rate of Alzheimer’s Decline (GENAROAD) ConsortiumGenomics EnglandGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Goethe University FrankfurtGuangdong Medical CollegeHelmholtz Association of German Research CentresHospital de Sant PauImperial College LondonJPND ResearchKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo Foundation for Medical Education and Research (MFMER)Medical Research Council (MRC)National Center for Biotechnology Information (NCBI)National Institute of Health and Medical Research (INSERM)National Institutes of Health (NIH)Neuroscience; IOPNewcastle UniversityOxford University Hospitals NHS Foundation TrustPasteur Institute, LillePopulation Genetics Technologies LtdQueen's University BelfastQuest DiagnosticsSaarland UniversitySevernside Alliance for Translational Research (SARTRE)Swansea UniversityThe Jackson LaboratoryTrinity College DublinUniversity College LondonUniversity Duisburg-EssenUniversity of BonnUniversity of BristolUniversity of CambridgeUniversity of CantabriaUniversity of ExeterUniversity of HamburgUniversity of LilleUniversity Of ManchesterUniversity of NavarraUniversity Of NottinghamUniversity of OviedoUniversity Of OxfordUniversity of PennsylvaniaUniversity of SouthamptonUniversity of WashingtonUniversity of ZurichVU University Medical CenterWashington University in St LouisWellcome Sanger Institute